title: Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
authors.affiliation: Department of Obstetrics and Gynaecology, Medical University of Graz, Austria. arnim.bader@meduni-graz.at
authors.forename: Arnim A
authors.initials: AA
authors.lastname: Bader
authors.forename: Dietmar
authors.initials: D
authors.lastname: Schlembach
authors.forename: Karl F
authors.initials: KF
authors.lastname: Tamussino
authors.forename: Gunda
authors.initials: G
authors.lastname: Pristauz
authors.forename: Edgar
authors.initials: E
authors.lastname: Petru
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D016104:Oligohydramnios / Q000139:chemically induced*; D017239:Paclitaxel / Q000008:administration & dosage; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068878:Trastuzumab; D017239:Paclitaxel